Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-01-23 00:00:00 ET · period of report 2026-01-21 · accession 0001193125-26-021377 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-23 | 2026-01-21 | AXSM | Maizel Ari | Chief Commercial Off | S - Sale+OE | $184.44 | -7,500 | 0 | -100% | -$1.38M |
| DT | 2026-01-23 | 2026-01-21 | AXSM | Maizel Ari | Chief Commercial Off | M - OptEx | $70.73 | +7,500 | 7,500 | New | +$530.5K |
| DT | 2026-01-23 | 2026-01-21 | AXSM | Maizel Ari | Chief Commercial Off | M - OptEx | $0.00 | -7,500 | 31.2K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-21 | S | D | 7,500 | $184.44 | 0 | D | — | — | (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $183.70 and $184.81. |
| 2 | Common | Common Stock | 2026-01-21 | M | A | 7,500 | $70.73 | 7,500 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-01-21 | M | D | 7,500 | $0.00 | 31,210 | D | $70.73 · 2024-09-25 to 2033-09-25 | 7,500 Common Stock |